XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Details)
12 Months Ended
Aug. 05, 2021
USD ($)
Installment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Employee Retirement Plan [Abstract]      
Employer's matching contribution   $ 293,000 $ 234,000
Koronis Biomedical Corporation [Member]      
Commitments and Contingencies [Abstract]      
Amount of grant approval received $ 1,700,000    
Non-refundable technology license fee $ 428,160    
Number of equal monthly installments | Installment 12    
Research and Development Expense [Member] | Koronis Biomedical Corporation [Member]      
Commitments and Contingencies [Abstract]      
Non-refundable technology license fee expenses   428,160  
Current Accounts Payable [Member] | Koronis Biomedical Corporation [Member]      
Commitments and Contingencies [Abstract]      
Non-refundable technology license fee   249,760  
Other Long-term Liabilities [Member] | Koronis Biomedical Corporation [Member]      
Commitments and Contingencies [Abstract]      
Non-refundable technology license fee   $ 178,400